USPTO serial 79257037
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $850
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi, Esq.
Christina M. Licursi, Esq. Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for developing, running and communicating with software on data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; laboratory equipment, namely, micro-array chips; electronic sensing apparatus for analysing chemical, biochemical, biological, bacteriological and microbiological test samples for scientific testing services; laboratory and scientific apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular test samples and the measurement of ions; laboratory and scientific portable apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular test samples and the measurement of ions; scientific apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing; scientific apparatus for the analysis of polynucleic acid sequences; scientific apparatus and instruments for the analysis of nucleic and polynucleic acids; scientific apparatus and instruments for the analysis of proteins; scientific apparatus and instruments for analysis of genetic information, genomic information and proteomic information; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples in the nature of cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; downloadable computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; electrowetting-on-dielectric (EWOD) devices for the display of scientific data; scientific apparatus and instruments for automating the extraction and preparation of test samples; scientific apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; data processing apparatus, devices and instruments for the analysis and recordal of scientific data; scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; electronic display interfaces for the display of information obtained from scientific equipment; silicon chips; DNA chips; biosensor chips for scientific research and scientific testing use; cartridges namely, cartridges for test samples and cartridges for use with concentrates and solutions in solid or liquid form for use in biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis; batteries; rechargeable batteries; chargers for batteries; power packs namely, battery packs; computer docking stations; testing apparatus incorporating chemical or biological reagents for medical purposes, namely, apparatus for testing gas, liquids and solids; reaction units containing chemical or biological reagents being laboratory equipment other than for medical use; scientific apparatus, namely, nanopore sensing devices; none of the aforesaid relating to entertainment, video games and interactive applications for entertainment purposes; none of the foregoing for clearing and settling exchange traded derivatives or smart card issuance and management, nor relating to quality monitoring and assessment of services, customer services, business processes and employee skills and performance | ACTIVE | — |
| 010 | Medical and veterinary testing and diagnostic apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; electrowetting-on-dielectric (EWOD) devices for medical and veterinary purposes; automated medical apparatus and instruments for the extraction and preparation of test samples for medical and veterinary purposes; portable medical and veterinary testing and diagnostic apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; liquid biopsy instruments; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; cartridges for test samples and cartridges for use with concentrates and solutions in solid or liquid form for medical use, detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; diagnostic apparatus and instruments in the nature of reaction units containing chemical reagents, namely, reaction systems for medical testing purposes, not for research purposes; medical apparatus, namely, nanopore sensing devices for medical purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 21, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 4, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 26, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 5, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 26, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 21, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 21, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 2, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Feb 24, 2020 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Feb 4, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 4, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 31, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 15, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 15, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 30, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 30, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 30, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 5, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 5, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 2, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 2, 2019 | ALIE | ASSIGNED TO LIE | — |
| Nov 22, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 9, 2019 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 22, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 31, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 31, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 7, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 6, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 26, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 25, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |